JP2024041834A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2024041834A5 JP2024041834A5 JP2024000086A JP2024000086A JP2024041834A5 JP 2024041834 A5 JP2024041834 A5 JP 2024041834A5 JP 2024000086 A JP2024000086 A JP 2024000086A JP 2024000086 A JP2024000086 A JP 2024000086A JP 2024041834 A5 JP2024041834 A5 JP 2024041834A5
- Authority
- JP
- Japan
- Prior art keywords
- formula
- pharma
- patient
- acceptable salt
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662315144P | 2016-03-30 | 2016-03-30 | |
| US62/315,144 | 2016-03-30 | ||
| JP2020007053A JP7594268B2 (ja) | 2016-03-30 | 2020-01-20 | 新規組成物及び治療方法 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020007053A Division JP7594268B2 (ja) | 2016-03-30 | 2020-01-20 | 新規組成物及び治療方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024041834A JP2024041834A (ja) | 2024-03-27 |
| JP2024041834A5 true JP2024041834A5 (https=) | 2025-03-28 |
Family
ID=59958482
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018549943A Pending JP2019513137A (ja) | 2016-03-30 | 2017-03-30 | 新規組成物及び治療方法 |
| JP2020007053A Active JP7594268B2 (ja) | 2016-03-30 | 2020-01-20 | 新規組成物及び治療方法 |
| JP2020139289A Active JP7357364B2 (ja) | 2016-03-30 | 2020-08-20 | 新規組成物及び治療方法 |
| JP2023151493A Active JP7774885B2 (ja) | 2016-03-30 | 2023-09-19 | 新規組成物及び治療方法 |
| JP2024000086A Pending JP2024041834A (ja) | 2016-03-30 | 2024-01-04 | 新規組成物及び治療方法 |
Family Applications Before (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018549943A Pending JP2019513137A (ja) | 2016-03-30 | 2017-03-30 | 新規組成物及び治療方法 |
| JP2020007053A Active JP7594268B2 (ja) | 2016-03-30 | 2020-01-20 | 新規組成物及び治療方法 |
| JP2020139289A Active JP7357364B2 (ja) | 2016-03-30 | 2020-08-20 | 新規組成物及び治療方法 |
| JP2023151493A Active JP7774885B2 (ja) | 2016-03-30 | 2023-09-19 | 新規組成物及び治療方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US11207343B2 (https=) |
| EP (1) | EP3436467B1 (https=) |
| JP (5) | JP2019513137A (https=) |
| KR (2) | KR102306956B1 (https=) |
| CN (2) | CN114712383B (https=) |
| AU (4) | AU2017244114B2 (https=) |
| BR (1) | BR112018067833B1 (https=) |
| CA (2) | CA3128743C (https=) |
| MX (1) | MX392849B (https=) |
| WO (1) | WO2017173024A1 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5548121B2 (ja) | 2007-05-14 | 2014-07-16 | リサーチ ファウンデーション オブ ステイト ユニバーシティ オブ ニューヨーク | バイオフィルム中の細菌細胞における生理学的分散応答の誘導 |
| JP2019513137A (ja) | 2016-03-30 | 2019-05-23 | アユヴィス リサーチ インク．Ａｙｕｖｉｓ Ｒｅｓｅａｒｃｈ， Ｉｎｃ． | 新規組成物及び治療方法 |
| US20220143059A1 (en) * | 2016-03-30 | 2022-05-12 | Ayuvis Research, Inc. | Compositions and therapeutic methods |
| US12594286B2 (en) | 2018-07-02 | 2026-04-07 | Ayuvis Research, Inc. | Immunodulating small molecules |
| KR20210027381A (ko) * | 2018-07-02 | 2021-03-10 | 아유비스 리서치, 인코포레이티드 | 신규 면역조절 소분자 |
| EP3820512B1 (en) * | 2018-07-02 | 2024-04-24 | Ayuvis Research, Inc. | Immunomodulating compositions comprising oligosaccharide derivatives |
| JP7382281B2 (ja) * | 2020-05-25 | 2023-11-16 | 株式会社東海理化電機製作所 | 制御装置および制御方法 |
| JP7382280B2 (ja) | 2020-05-25 | 2023-11-16 | 株式会社東海理化電機製作所 | 制御装置および制御方法 |
| WO2022169855A1 (en) * | 2021-02-04 | 2022-08-11 | Ayuvis Research, Inc. | Chitin analogs for the treatment of kidney diseases |
| US12440471B2 (en) * | 2021-07-30 | 2025-10-14 | Ayuvis Research, Inc. | Compositions and methods for the treatment of bronchopulmonary dysplasia (BPD) and BPD-associated pulmonary hypertension |
| WO2023086877A1 (en) * | 2021-11-12 | 2023-05-19 | Ayuvis Research, Inc. | Novel compositions and therapeutic methods |
Family Cites Families (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3931319A (en) | 1974-10-29 | 1976-01-06 | Millmaster Onyx Corporation | Capped polymers |
| US4027020A (en) | 1974-10-29 | 1977-05-31 | Millmaster Onyx Corporation | Randomly terminated capped polymers |
| US4152413A (en) | 1978-08-18 | 1979-05-01 | Chromalloy American Corporation | Oral vaccine for swine dysentery and method of use |
| US4525346A (en) | 1981-09-28 | 1985-06-25 | Alcon Laboratories, Inc. | Aqueous antimicrobial ophthalmic solutions |
| US4407791A (en) | 1981-09-28 | 1983-10-04 | Alcon Laboratories, Inc. | Ophthalmic solutions |
| US4836986A (en) | 1984-09-28 | 1989-06-06 | Bausch & Lomb Incorporated | Disinfecting and preserving systems and methods of use |
| US4621075A (en) | 1984-11-28 | 1986-11-04 | The Procter & Gamble Company | Gel-form topical antibiotic compositions |
| CA1261264A (en) | 1984-11-29 | 1989-09-26 | Shigeo Suzuki | Immunopotentiating agents and method |
| JPH0615476B2 (ja) * | 1985-05-22 | 1994-03-02 | イハラケミカル工業株式会社 | 抗感染症剤 |
| US5037647A (en) | 1988-09-15 | 1991-08-06 | Alcon Laboratories, Inc. | Aqueous antimicrobial opthalmic solutions comprised of quaternary ammonium compound, citric acid, citrate and sodium chloride |
| FR2640627A1 (fr) * | 1988-12-16 | 1990-06-22 | Commissariat Energie Atomique | Nouveaux fluorures d'aldosaminyle, leur preparation et leur utilisation pour la fabrication d'oligosaccharides amines lies (1 -> 4) |
| US5932640A (en) | 1989-01-21 | 1999-08-03 | Clariant Finance (Bvi) Limited | Dyeability or mass coloration of synthetic polyamide |
| US5145643A (en) | 1990-01-05 | 1992-09-08 | Allergan, Inc. | Nonoxidative ophthalmic compositions and methods for preserving and using same |
| JPH041115A (ja) | 1990-04-13 | 1992-01-06 | Pola Chem Ind Inc | 皮膚外用剤 |
| EP0570682B1 (en) | 1992-05-07 | 1997-07-23 | American Cyanamid Company | Synthetic lipid A glycoconjugate antigens for use in vaccines |
| US5300287A (en) | 1992-11-04 | 1994-04-05 | Alcon Laboratories, Inc. | Polymeric antimicrobials and their use in pharmaceutical compositions |
| US5681824A (en) * | 1995-06-05 | 1997-10-28 | Eisai Co., Ltd. | Substituted liposaccharides useful in the treatment and prevention of endotoxemia |
| AU7484198A (en) | 1997-05-12 | 1998-12-08 | Sage Pharmaceuticals, Inc. | Topical spray for burn treatment and anti-infection |
| US6492350B2 (en) | 2000-01-27 | 2002-12-10 | Jdc (Hawaii) Inc. | Chitin oligosaccharides and/or chitosan oligosaccharides for preventing or treating common cold or treating pain |
| SE0100172D0 (sv) * | 2001-01-22 | 2001-01-22 | Ulf Nilsson | New inhibitors against galectins |
| US7098195B2 (en) * | 2001-11-28 | 2006-08-29 | Health Research, Inc. | Fluorinated glucosamine analogs useful for modulating post-translational glycosylations on cells |
| EP1455835A2 (en) * | 2001-12-13 | 2004-09-15 | ISM Biopolymer Inc. | Method of modulating release of saccharides and uses thereof |
| AU2003211574A1 (en) * | 2002-03-05 | 2003-09-16 | Ono Pharmaceutical Co., Ltd. | 8-azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient |
| US7632654B2 (en) * | 2002-04-29 | 2009-12-15 | Academisch Ziekenhuis Bij De Universiteit Van Amsterdam | Means and methods for detecting endoglycosidase activity |
| EP1440683A1 (de) | 2003-01-23 | 2004-07-28 | Cognis France S.A. | Verwendung von Oligoglucosaminen in kosmetischen oder dermatologischen Zubereitungen |
| CA2428744C (en) | 2003-01-24 | 2013-06-25 | University Of Manitoba | Inhibition of lysozyme in treating sepsis-induced myocardial dysfunction |
| US20050255048A1 (en) | 2004-05-15 | 2005-11-17 | Collegium Pharmaceutical, Inc. | Sprayable formulations for the treatment of acute inflammatory skin conditions |
| JP5035787B2 (ja) | 2005-10-04 | 2012-09-26 | 焼津水産化学工業株式会社 | α−１、４結合型Ｎ−アセチルグルコサミン含有Ｏ−グリカン型糖鎖の分泌促進剤並びにこれを含有するヘリコバクターピロリ菌を原因とする病態の治療予防剤 |
| FR2892419A1 (fr) * | 2005-10-24 | 2007-04-27 | Univ Claude Bernard Lyon I Eta | Heteroligomeres de d-glucasamine et n-acetyl-d-glucosamine, leur procede de preparation et leur utilisation |
| JP5140246B2 (ja) * | 2006-03-15 | 2013-02-06 | 公益財団法人野口研究所 | Ｎ−アセチルグルコサミンの誘導体を含有するピロリ菌増殖抑制剤 |
| GB0622688D0 (en) * | 2006-11-14 | 2006-12-27 | Diosamine Dev Corp | Novel compounds |
| ES2543063T3 (es) * | 2008-05-16 | 2015-08-14 | Galecto Biotech Ab | Nueva síntesis de inhibidores de galactósidos |
| CN101732338A (zh) | 2008-11-26 | 2010-06-16 | 中国科学院大连化学物理研究所 | 壳六糖在制备预防血管生成的药物中的应用 |
| US9072760B2 (en) | 2010-09-24 | 2015-07-07 | University of Pittsburgh—of the Commonwealth System of Higher Education | TLR4 inhibitors for the treatment of human infectious and inflammatory disorders |
| CN102475714A (zh) | 2010-11-29 | 2012-05-30 | 中国科学院大连化学物理研究所 | 壳寡糖单一化合物在免疫增强药物中的应用 |
| WO2012129802A1 (en) * | 2011-03-31 | 2012-10-04 | Alectos Therapeutics Inc. | Pyrano[3,2-d]thiazol derivatives and uses as selective glycosidase inhibitors thereof |
| EP2885323B1 (en) | 2012-08-17 | 2023-08-30 | The University of North Carolina At Chapel Hill | Water soluble nitric oxide-releasing polyglucosamines and uses thereof |
| EP3001838A4 (en) | 2013-05-14 | 2017-02-08 | Medlmmune, LLC | Synthetic oligosaccharide subunits of the psl exopolysaccharide of pseudomonas aeruginosa and uses therof |
| JP2019513137A (ja) | 2016-03-30 | 2019-05-23 | アユヴィス リサーチ インク．Ａｙｕｖｉｓ Ｒｅｓｅａｒｃｈ， Ｉｎｃ． | 新規組成物及び治療方法 |
| JP7246205B2 (ja) * | 2019-02-27 | 2023-03-27 | センクシア株式会社 | デッキプレート |
-
2017
- 2017-03-30 JP JP2018549943A patent/JP2019513137A/ja active Pending
- 2017-03-30 CA CA3128743A patent/CA3128743C/en active Active
- 2017-03-30 EP EP17776618.5A patent/EP3436467B1/en active Active
- 2017-03-30 CN CN202210500974.0A patent/CN114712383B/zh active Active
- 2017-03-30 CN CN201780018429.5A patent/CN108884121B/zh active Active
- 2017-03-30 US US15/473,904 patent/US11207343B2/en active Active
- 2017-03-30 WO PCT/US2017/024908 patent/WO2017173024A1/en not_active Ceased
- 2017-03-30 KR KR1020187031371A patent/KR102306956B1/ko active Active
- 2017-03-30 MX MX2018009802A patent/MX392849B/es unknown
- 2017-03-30 CA CA3015494A patent/CA3015494C/en active Active
- 2017-03-30 BR BR112018067833-3A patent/BR112018067833B1/pt active IP Right Grant
- 2017-03-30 AU AU2017244114A patent/AU2017244114B2/en active Active
- 2017-03-30 KR KR1020217030430A patent/KR102532825B1/ko active Active
-
2020
- 2020-01-20 JP JP2020007053A patent/JP7594268B2/ja active Active
- 2020-08-20 JP JP2020139289A patent/JP7357364B2/ja active Active
-
2021
- 2021-09-15 AU AU2021232715A patent/AU2021232715A1/en not_active Abandoned
-
2023
- 2023-08-29 AU AU2023222844A patent/AU2023222844A1/en not_active Abandoned
- 2023-09-19 JP JP2023151493A patent/JP7774885B2/ja active Active
-
2024
- 2024-01-04 JP JP2024000086A patent/JP2024041834A/ja active Pending
-
2025
- 2025-07-09 AU AU2025205307A patent/AU2025205307A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024041834A5 (https=) | ||
| ES2242351T3 (es) | Derivados de imidazol sustituidos y su uso como inhibidores de citoquina. | |
| DE60129116T2 (de) | 7- und 9-carbamat, harnstoff, thioharnstoff, thiocarbamat und heteroaryl-amino substituierte tetracyclinverbindungen | |
| DE69322254T2 (de) | Pyridyl-substituierte imidazole | |
| JP4738333B2 (ja) | ９−アミノメチルテトラサイクリン化合物のプロドラッグ | |
| JP2784847B2 (ja) | ９−（置換アミノ）−アルファ−６−デオキシ−５−オキシテトラサイクリン誘導体、それらの製造及び、抗生物質としてのそれらの使用 | |
| CA2102457C (fr) | Derives de l'erythromycine, leur procede de preparation, leur application comme medicaments | |
| EP0606024B1 (fr) | Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments | |
| RU2015137928A (ru) | Полиморфные и псевдоплиморфные формы фармацевтического соединения | |
| EP0799833A1 (fr) | Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments | |
| HU215445B (hu) | 9-Szubsztituált-6-demetil-6-dezoxi-tetraciklinek és ilyen vegyületeket tartalmazó gyógyszerkészítmények és eljárás ezek előállítására | |
| DE69627985T2 (de) | Heterozyklische verbindungen | |
| DE69007471T2 (de) | Verfahren zur verhütung oder zur begrenzung einer reperfusionsschädigung. | |
| DE1795188B2 (de) | 3-Alkoxymethylcephalosporine, Verfahren zu deren Herstellung und die diese enthaltenden pharmazeutischen Zusammensetzungen | |
| KR950702554A (ko) | 소염제로서 유용한 2-헤테로시클릭-5-히드록시-1,3-피리미딘 (2-Heterocyclic-5-Hydroxy-1,3-Pyrimidines Useful as Antiinflammatory Agents) | |
| CH617204A5 (https=) | ||
| DE69829682T2 (de) | Cis-disubstituierte aminocycloalkyl-pyrrolidin-derivate | |
| EP0931088B1 (fr) | Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments | |
| CA1132537A (fr) | Procede de preparation de nouvelles oximes derivees de l'acide 3-thiadiazolyl thiomethyl 7-aminothiazolyl acetamido cephalosporanique | |
| CN1018648B (zh) | 抗菌的9-脱氧-9a-烯丙基和炔丙基-9a-氮杂-9a-类红霉素A衍生物的制备方法 | |
| CH651572A5 (fr) | Alcoyloximes substituees derivees de l'acide 7-(2-amino 4-thiazolyl)acetamido cephalosporanique, leur preparation et les compositions les renfermant. | |
| JP2022536043A5 (https=) | ||
| DD250710A5 (de) | Verfahren zur herstellung von carbapenem-derivaten | |
| AT393269B (de) | Verfahren zur herstellung von oxazino-(5,6-c)-1,2-benzothiazin-6,6-dioxid | |
| DE2653621A1 (de) | Cephalosporin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |